Federal Register / Vol. 86, No. 6 / Monday, January 11, 2021 / Notices 1975 

Control No. 9000–0153, Alternatives to 

Government-Unique Standards. 

William F. Clark, 

Director, Office of Government-Wide 

Acquisition Policy, Office of Acquisition 

Policy, Office of Government-Wide Policy. 

[FR Doc. 2021–00265 Filed 1–8–21; 8:45 am] 

BILLING CODE 6820–EP–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Disease, Disability, and Injury 

Prevention and Control Special 

Emphasis Panel (SEP)—RFA–CK–21– 

001, US Travelers Health Research, 

Surveillance, Communication, and 

Outreach Network; RFA–CK–21–002, 

Emerging Infections Network— 

Research for Preventing, Detecting, 

and Managing Travelers who Acquire 

Infectious Diseases Abroad; and RFA– 

CK–21–003, Monitoring Cause-specific 

School Absenteeism for Estimating 

Community-wide Influenza and SARSCoV–2 Transmission; Amended Notice 

of Meeting 

Notice is hereby given of a change in 

the meeting of the Disease, Disability, 

and Injury Prevention and Control 

Special Emphasis Panel (SEP)—RFA– 

CK–21–001, US Travelers Health 

Research, Surveillance, Communication, 

and Outreach Network; RFA–CK–21– 

002, Emerging Infections Network— 

Research for Preventing, Detecting, and 

Managing Travelers who Acquire 

Infectious Diseases Abroad; and RFA– 

CK–21–003, Monitoring Cause-specific 

School Absenteeism for Estimating 

Community-wide Influenza and SARSCoV–2 Transmission; February 10–11, 

2021, 10:00 a.m.—5:00 p.m., EST. 

Teleconference, Centers for Disease 

Control and Prevention, Room 1080, 8 

Corporate Square Blvd., Atlanta, GA 

30329 which was published in the 

Federal Register on November 30, 2020, 

Volume 85, Number 230, pages 76575– 

76576. 

The meeting is being amended to 

change the meeting date to February 10, 

2021. The meeting is closed to the 

public. 

FOR FURTHER INFORMATION CONTACT: 

Gregory Anderson, M.S., M.P.H., 

Scientific Review Officer, CDC, 1600 

Clifton Road, NE, Mailstop US8–1, 

Atlanta, Georgia 30329–4027, (404) 718– 

8833, ganderson@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–00280 Filed 1–8–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

RFA–PS–21–002, Implementation 

Research Consortium to Accelerate 

Impact of Health Department-Delivered 

HIV Prevention Activities. 

Date: March 23, 2021. 

Time: 10:00 a.m.–5:00 p.m., EDT. 

Place: Teleconference, Centers for 

Disease Control and Prevention, Room 

1080, 8 Corporate Square Boulevard, 

Atlanta, Georgia 30329–4027. 

Agenda: To review and evaluate grant 

applications. 

FOR FURTHER INFORMATION CONTACT: 

Gregory Anderson, M.S., M.P.H., 

Scientific Review Officer, CDC, 1600 

Clifton Road, NE, Mailstop US8–1, 

Atlanta, Georgia 30329–4027, (404) 718– 

8833, ganderson@cdc.gov. 

The Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, Centers for Disease 

Control and Prevention, has been 

delegated the authority to sign Federal 

Register notices pertaining to 

announcements of meetings and other 

committee management activities, for 

both the Centers for Disease Control and 

Prevention and the Agency for Toxic 

Substances and Disease Registry. 

Kalwant Smagh, 

Director, Strategic Business Initiatives Unit, 

Office of the Chief Operating Officer, Centers 

for Disease Control and Prevention. 

[FR Doc. 2021–00284 Filed 1–8–21; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Notice of Closed Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

following meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended, and the Determination of 

the Director, Strategic Business 

Initiatives Unit, Office of the Chief 

Operating Officer, CDC, pursuant to 

Public Law 92–463. The grant 

applications and the discussions could 

disclose confidential trade secrets or 

commercial property such as patentable 

material, and personal information 

concerning individuals associated with 

the grant applications, the disclosure of 

which would constitute a clearly 

unwarranted invasion of personal 

privacy. 

Name of Committee: Disease, 

Disability, and Injury Prevention and 

Control Special Emphasis Panel (SEP)— 

Funding Opportunity Announcement 

(FOA), PAR 20–280, Cooperative 

Research Agreements to the World 

Trade Center Health Program (U01); and 

RFA OH–21–004, Exploratory/ 

Developmental Grants Related to the 

World Trade Center Health Program 

(R21). 

Dates and Times: March 16–17, 2021, 

from 9:00 a.m.–6:00 p.m., EDT; and 

March 18, 2021, from 9:00 a.m.–12:00 

p.m., EDT. 

Place: Virtual. 

Agenda: To review and evaluate grant 

applications. 

FOR FURTHER INFORMATION CONTACT: 

Marilyn Ridenour, B.S.N., M.B.A., 

M.P.H., C.P.H., C.I.C., CAPT, USPHS, 

Scientific Review Officer, CDC, National 


jbell on DSKJLSW7X2PROD with NOTICES